retatrutide nash trial FDA Approves First Drug & Other Pipelines in Clinical Trials Resmetirom Resolves NASH and Lessens
Description
doi: 10.1016/j.jacc.2022.11.005 2 MarxNHusainMLehrkeMVermaSSattarN
Patent protection plays an indispensable role in that process
This choice affects cost, safety, convenience, and long-term access
Progress does not require perfection
